J2400 HCPCS code: Injection, chloroprocaine hydrochloride, per 30 ml
J2400 is the HCPCS Level II code for injection, chloroprocaine hydrochloride, per 30 ml. CMS terminated J2400 on 2022-12-31; do not bill it for later dates of service. In 2022 Medicare paid an average of $20.86 per service for J2400 across 2,641 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. In 2022, about 14 clinicians billed Medicare for J2400 for 245 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1986-01-01 |
| Last action effective | 2023-01-01 |
| Terminated | 2022-12-31 |
Who bills J2400 (2022)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 14 |
| Medicare beneficiaries | 245 |
| States with claims | 4 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2400, 2022–2022
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 2,641 | 245 | $26.34 | $20.86 |
States with the most J2400 services (2022)
| State | Services | Avg. paid |
|---|---|---|
| Nevada | 2,159 | $20.84 |
| Georgia | 230 | $24.07 |
| Alabama | 146 | $24.08 |
| California | 94 | $9.66 |
What changed for J2400
- 1986-01-01: J2400 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2400?
J2400 is the HCPCS Level II code for injection, chloroprocaine hydrochloride, per 30 ml. Short descriptor: "Chloroprocaine hcl injection".
How much does Medicare pay for J2400?
In 2022, the average Medicare payment was $20.86 per service (average allowed $26.34).
Does Medicare cover J2400?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
Related J24 codes
- J2401 — Injection, chloroprocaine hydrochloride, per 1 mg
- J2402 — Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg
- J2403 — Chloroprocaine hcl ophthalmic, 3% gel, 1 mg
- J2404 — Injection, nicardipine, 0.1 mg
- J2405 — Injection, ondansetron hydrochloride, per 1 mg
- J2406 — Injection, oritavancin (kimyrsa), 10 mg
- J2407 — Injection, oritavancin (orbactiv), 10 mg
- J2410 — Injection, oxymorphone hcl, up to 1 mg
- J2425 — Injection, palifermin, 50 micrograms
- J2426 — Injection, paliperidone palmitate extended release (invega sustenna), 1 mg
- J2427 — Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg
- J2428 — Injection, paliperidone palmitate extended release (erzofri), 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2400
- Watch J2400 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2400
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.